Titre:
  • Fenticonazole activity measured by the methods of the European Committee on Antimicrobial Susceptibility Testing and CLSI against 260 Candida vulvovaginitis isolates from two European regions and annotations on the prevalent genotypes.
Auteur:Antonopoulou, Stavroula; Aoun, Michel; Alexopoulos, Evangelos C; Baka, Stavroula; Logothetis, Emanuel; Kalambokas, Theodoros; Zannos, Andreas; Papadias, Konstantine; Grigoriou, Odysseas; Kouskouni, Evangelia; Velegraki, Aristea
Informations sur la publication:Antimicrobial agents and chemotherapy, 53, 5, page (2181-2184)
Statut de publication:Publié, 2009-05
Sujet CREF:Cancérologie
MeSH keywords:Adult
Antifungal Agents -- pharmacology
Candida albicans -- classification -- drug effects -- genetics
Candida glabrata -- classification -- drug effects -- genetics
Candidiasis, Vulvovaginal -- epidemiology -- microbiology
Cluster Analysis
DNA Fingerprinting -- methods
Drug Resistance, Fungal
Europe -- epidemiology
Female
Fluconazole -- pharmacology
Genotype
Humans
Imidazoles -- pharmacology
Itraconazole -- pharmacology
Ketoconazole -- pharmacology
Microbial Sensitivity Tests -- methods -- standards
Polymerase Chain Reaction
Pregnancy
Pregnancy Complications, Infectious -- epidemiology -- microbiology
Prevalence
Note générale:Journal Article
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0066-4804
info:doi/10.1128/AAC.01413-08
info:pii/AAC.01413-08
info:scp/66149101594
info:pmid/19223627
PMC2681495